Alnylam Pharmaceuticals earnings (net income)
Alnylam Pharmaceuticals (ALNY) earned a net income of $313.75 M in fiscal year 2025, — compared with the year before. Net profit margin: 8.45% of revenue.
Earnings 2025$313.75 M
Change—
World rank#755
Market cap$20.01 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $313.75 M | — |
| 2024 | −$278.16 M | — |
| 2023 | −$440.24 M | — |
| 2022 | −$1.13 B | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.